[1] 王辉,陈民钧.1994~2001年中国重症监护病房非发酵糖细菌的耐药变迁[J].中华医学杂志,2003,83(5):385-390.[2] Chen M J, Wang H. China Nosocomial Pathogens Resistance Surveillance Study Group.Continuous surveillance of antimicrobial resistance among nosocomial gramnegative bacilli from intensive care units in China[J].Zhonghua Yi xue Za Zhi,2003,83(5):375-381.[3] Vieira A, Silva Y J,Cunha Â. Phage therapy to control multidrug-resistant pseudomonas aeruginosa skin infections: in vitro and ex vivo experiments[J]. Eur J Clin Microbiol Infect Dis, 2012, 31(11):3241-3249.[4] Glukhov A S, Krutilina A I, Shlyapnikov M G, et al.Genomic analysis of pseudomonas putida phage tf with localized single-strand DNA interruptions[J].Plos One,2012,7(12):e51163.[5] Li L, Yang H, Lin S, et al.Classification of 17 newly isolated virulent bacteriophages of pseudomonas aeruginosa[J].Can J Microbiol,2010,56(11):925-933.[6] 马列婷,杨朵,王亚文.rep-PCR检测产ESBL大肠埃希菌[J].临床检验杂志, 2005,2(1):110-111.[7] Rao B M,Surendran P K. Genetic heterogeneity of non-O1 and non-O139 Vibrio cholerae isolates from shrimp aquaculture system: a comparison of RS-,REP-and ERIC-PCR fingerprinting approaches[J]. Lett Appl Microbiol,2010,51(1):65-74.[8] Knezevic P, Curcin S, Aleksic V, et al. Phage-antibiotic synergism: a possible approach to combating pseudomonas aeruginosa[J]. Res Microbiol, 2013, 164(1):55-60[9] 马淙,周厚湘,李海灵,等.铜绿假单胞菌耐药性及泛耐药临床因素分析[J].中国感染控制杂志,2009,8(4):274-276.[10] 刘建华,周秀珍,张智洁,等.重症监护病房革兰阴性菌分布及耐药性变迁[J].中国医科大学学报,2011,40(11):1036-1039[11] 胡北,王晶,严群,等.噬菌体治疗实验性小鼠耐亚胺培南铜绿假单胞菌感染的研究[J].中华微生物学和免疫学杂志,2006,26(5):438-441.[12] McVay C S,Velasquez M, Fralick J A. Phage therapy of pseudomonas aeruginosa infection in a mouse burn wound model[J].Antimicrob Agents Chemother,2007,51(6):1934-1938.[13] 颜沛云,杨浩,苏晓明,等.我院近五年铜绿假单胞菌耐药性分析[J].中国煤炭工业医学杂志,2012,15(12):1883-1887.[14] 陈晓春,王继文,曹永长,等. 噬菌体在疾病治疗方面的应用及研究[J].动物医学进展,2005,26(1):32-35.[15] 潘博,付文卓,王晓娜,等.用于大容量人源天然噬菌体 抗体库的表达载体的构建及鉴定[J]. 首都医科大学学报,2012,33(5):647-652.[16] 浦昭和.噬菌体——制服病菌的新武器[J].首都医药,2002,9(6):29.[17] Carter C D,Parks A, Abuladze T, et al. Bacteriophage cocktail significantly reduces Escherichia coli O157: H7 contamination of lettuce and beef, but does not protect against recontamination[J]. Bacteriophage,2012,2(3):178-185.[18] Jaiswal A, Koley H, Ghosh A, et al.Efficacy of cocktail phage therapy in treating Vibrio cholerae infection in rabbit model[J].Microbes Infect,2012,15(2):152-156.[19] Sarker S A,McCallin S, Barretto C, et al.Oral T4-like phage cocktail application to healthy adult volunteers from Bangladesh[J].Virology,2012,434(2):222-232. |